Boulder, Colorado – QalibreMD, Inc. Elizabeth Mirowski, CEO, today announced that it will present at Biotech Showcase ™ 2018, to be held January 8–10 during the most important week in healthcare at the Hilton San Francisco Union Square.
Elizabeth Mirowski will present at the Biotech Showcase™ as follows:
Date: Wednesday, January 10, 2018
Time: 9:30am (PST)
Room: B-Cyril Magnin III (4th Floor)
Venue: Hilton San Francisco Union Square Hotel, 333 O’Farrell Street, San Francisco, CA (United States)
QalibreMD’s strategy is to transform medical imaging from a simple diagnosis of a lesion, to an exact diagnosis of what disease is present at what stage and to what extent in the body. “Our imaging standards certify the accuracy of MRI scanners to reduce unnecessary repeat scans and variability in diagnoses from one health center to another” says CEO Elizabeth Mirowski. “We’ve had customers develop new MRI protocols that reduce scan time down to 5 minutes and without contrast agents.” Packaged as a plug-and-play service, QalibreMD’s products will make it easy for hospitals to run QC overnight when scanners are idle.
Biotech Showcase™, produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences, J.P. Morgan Annual Healthcare Conference.
Sara Demy-Colton, CEO of Demy-Colton, said: “We are delighted that QalibreMD will be presenting at Biotech Showcase this year. Biotech Showcase is the perfect platform for life science companies to showcase their innovation and seek out their next deal. This year again we are thrilled to be hosting what we believe will be the great business development opportunity of 2018.”